• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HALYARD - IRVINE SURGPN,600X1-7D,CB SAF,-,OQ,5; ELASTOMERIC - SAF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HALYARD - IRVINE SURGPN,600X1-7D,CB SAF,-,OQ,5; ELASTOMERIC - SAF Back to Search Results
Model Number CB6007
Device Problem Infusion or Flow Problem (2964)
Patient Problems Tinnitus (2103); Toxicity (2333); Numbness (2415); Confusion/ Disorientation (2553)
Event Date 09/24/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The actual complaint product was not returned for evaluation.A review of the device history record for the reported lot is in-progress.Upon completion of the investigation, a follow-up report will be filed.Halyard health has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.(b)(4).
 
Event Description
Fill volume: 750 ml, flow rate: unknown ml/hr, procedure: cardiac surgery, pump start time: unknown time on (b)(6) 2016, pump end time: unknown time on (b)(6) 2016.It was reported that a pump showed local toxicity on a patient with symptoms in the form of ringing in the ear, a metallic taste in the mouth, confusion, and peri-oral numbness.The symptoms occurred greater than 48 hours into the infusion.The patient was reported as fine and being disconnected from the pump.An anesthesiologist believed the patient was laying on the ball.
 
Manufacturer Narrative
The pump was returned empty.The distal luer on line #1 appeared to be missing due to damage.A new luer was added with cyclohexanone.A baxa repeater pump was used to refill the pump with 600ml of 0.9% saline.The pinch clamps were opened and the (select-a-flow) safs infused at all selectable flow rates.Flow accuracy testing was performed on the pump with each saf set to 6ml/hr.After 65 hours of testing, the pump yielded a flow rate on saf #1 of 3.20ml/hr and on saf #2 of 3.19 for a combined rate of 6.39ml/hr which is within specification with a with a +/- 20% tolerance.Pressure pot testing was performed on the selected-a-flow unit flow rates 1ml/hr, 2ml/hr, 4ml/hr and 7ml/hr without the filter.The saf units were detached from the pump.The saf units were connected to a pressure gauge.The average bladder pressure used was 7.13psi.The saf #1 flow 1ml/hr did not flow.The 1ml/hr flow on saf #2 yielded a rate of 1.11ml/hr, which is within specifications with a +/-20% tolerance.The 2ml/hr flow on saf #1 yielded a rate of 2.10ml/hr, which is within specifications with a +/-20% tolerance.The 2ml/hr flow on saf #2 yielded a rate of 2.18ml/hr, which is within specifications with a +/-20% tolerance.Flow rate 4ml/hr on saf #1 yielded a flow rate of 4.17ml/hr which is within specifications with a +/- 20% tolerance.Flow rate 4ml/hr on saf #2 yielded a flow rate of 4.20ml/hr which is within specifications with a +/- 20% tolerance.Flow rate 7ml/hr on saf #1 yielded a flow rate of 5.34ml/hr which is within specifications with a +/- 20% tolerance.Flow rate 7ml/hr on saf #2 yielded a flow rate of 6.00ml/hr which is within specifications with a +/- 20% tolerance.A dremel was used to cut open the saf #1 and the flow control tubing observed under magnification.Crystalized medication was found in the 1ml/hr flow control tubing.The evaluation summary concluded that fast flow was not observed.During the flow accuracy test, the pump met specifications.During pressure pot testing, all flow rates met specifications using the average bladder pressure with the exception of the 1ml/hr rate on saf #1 which did not flow.At the start of the infusion verification it flowed indicating that it was obstructed after.Destructive analysis found crystalized medication in the 1ml/hr flow control tubing in saf #1.Based on the sample evaluation the root cause of the reported incident is unknown.The pump met all selectable flow rates during the flow rate testing.During pressure pot testing the saf#1 did not flow at 1ml/hr.The remaining flow rates were observed using the average bladder pressure during pressure pot testing.Crystalized medication was observed during destructive analysis for saf#1 at 1mlhr.A use review was performed to evaluate if the product was used appropriately, comparing use conditions with the requirements of the device instructions for use and labeling information.Based on the use review, it was observed that the user seemed to be laying on pump which could have been the potential cause of increased flow rate.None of the potential factors listed in the instructions for use were identified as the cause for the fast flow condition.However the sample investigation concluded that fast flow was not observed.Review of the dhr identified no issues observed during the manufacturing process which would have contributed to the incident observed.Therefore the root cause is unknown.Halyard health has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the halyard health complaint database and identified as complaint (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGPN,600X1-7D,CB SAF,-,OQ,5
Type of Device
ELASTOMERIC - SAF
Manufacturer (Section D)
HALYARD - IRVINE
43 discovery
suite 100
irvine CA 92618
Manufacturer (Section G)
AVENT S. DE R.L. DE C.V.
ave noruega edificio d-1b
fraccionamiento rubio
tijuana, b.c.
Manufacturer Contact
lisa clark
5405 windward parkway
alpharetta, GA 30004
4704485444
MDR Report Key6073578
MDR Text Key59352481
Report Number2026095-2016-00185
Device Sequence Number1
Product Code MEB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PK063530
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/31/2018
Device Model NumberCB6007
Device Catalogue Number101347700
Device Lot Number0202361760
Other Device ID Number30680651134777
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/12/2016
Initial Date FDA Received11/02/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/21/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/21/2016
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
I-FLOW CATHETER
Patient Age52 YR
Patient Weight130
-
-